- Report
- January 2026
- 186 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- January 2026
Global
From €6720EUR$7,500USD£5,756GBP
- Report
- July 2026
- 186 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- June 2026
- 197 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- June 2026
- 196 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- July 2026
- 190 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- June 2026
- 197 Pages
Global
From €3176EUR$3,545USD£2,721GBP
€3529EUR$3,939USD£3,023GBP
- Report
- August 2025
- 185 Pages
Global
From €4032EUR$4,500USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €4023EUR$4,490USD£3,446GBP
- Report
- August 2026
- 501 Pages
Global
From €5242EUR$5,850USD£4,490GBP
- Report
- August 2026
- 282 Pages
Global
From €5242EUR$5,850USD£4,490GBP
- Report
- August 2026
- 565 Pages
Global
From €5242EUR$5,850USD£4,490GBP
- Report
- May 2026
- 180 Pages
Global
From €4256EUR$4,750USD£3,646GBP
- Report
- July 2026
- 160 Pages
Global
From €3718EUR$4,150USD£3,185GBP
- Report
- April 2026
- 160 Pages
Global
From €2975EUR$3,320USD£2,548GBP
€3718EUR$4,150USD£3,185GBP
- Report
- May 2026
- 52 Pages
Global
From €6720EUR$7,500USD£5,756GBP
- Report
- September 2025
- 373 Pages
Europe
From €5372EUR$5,995USD£4,601GBP
- Report
- September 2025
- 435 Pages
North America
From €5372EUR$5,995USD£4,601GBP
- Report
- September 2025
- 472 Pages
Asia Pacific
From €5372EUR$5,995USD£4,601GBP
- Report
- March 2022
- 405 Pages
Global
From €4300EUR$4,799USD£3,683GBP

The EGFR Test is a type of In Vitro Diagnostics (IVD) used to detect the presence of epidermal growth factor receptor (EGFR) mutations in a patient's tumor. It is used to help diagnose and treat certain types of cancer, such as non-small cell lung cancer. The test is typically performed on a sample of tissue taken from the patient's tumor. The results of the test can help doctors determine the best course of treatment for the patient.
The EGFR Test market is a subset of the larger IVD market, which is estimated to be worth billions of dollars. The EGFR Test market is expected to grow in the coming years due to the increasing prevalence of cancer and the need for more accurate and personalized treatments.
Some of the major players in the EGFR Test market include Roche, Abbott, Qiagen, Thermo Fisher Scientific, and Agilent Technologies. Show Less Read more